ESMO 2025; Christof Vulsteke MD PhD: Perioperative Enfortumab Vedotin Therapy With Pembrolizumab Boosts Event-Free and Overall Survival in Platinum-Ineligible Patients with Muscle-Invasive Bladder Cancer: KEYNOTE-905 study
episode
Audio Journal of Oncology Podcast
not yet transcribed
Transcript
This episode hasn't been transcribed yet
Upvotes decide what gets transcribed next — 0 so far.
Sign in to upvote
Related
recent transcribed audio
The Ezra Klein Show: Jensen Huang Thinks A.I. Alarmism Has Gone Too Far
Pretty Little Episode #110
Be Upfront About How You Make Money From Your Podcast
High Stakes US-China Sit Down & Flock Surveillance Under Scrutiny | 9.25.26
Trump Spooked by Plane at Xi Meeting & Sen. Tuberville Rails Against Flying Furries | Merritt Wever
Ireland collapse in Kosovo as Israel game looms